1. Home
  2. KR vs NTRA Comparison

KR vs NTRA Comparison

Compare KR & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kroger Company (The)

KR

Kroger Company (The)

HOLD

Current Price

$62.24

Market Cap

38.9B

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$230.98

Market Cap

32.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KR
NTRA
Founded
1883
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Food Chains
Medical Specialities
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.9B
32.9B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
KR
NTRA
Price
$62.24
$230.98
Analyst Decision
Buy
Strong Buy
Analyst Count
13
15
Target Price
$72.54
$249.53
AVG Volume (30 Days)
6.7M
1.1M
Earning Date
03-05-2026
02-26-2026
Dividend Yield
2.27%
N/A
EPS Growth
N/A
N/A
EPS
1.16
N/A
Revenue
$147,225,000,000.00
$2,116,676,000.00
Revenue This Year
$3.78
$33.77
Revenue Next Year
$2.10
$16.92
P/E Ratio
$53.21
N/A
Revenue Growth
N/A
38.17
52 Week Low
$58.60
$125.38
52 Week High
$74.90
$256.36

Technical Indicators

Market Signals
Indicator
KR
NTRA
Relative Strength Index (RSI) 47.68 44.36
Support Level $61.02 $229.14
Resistance Level $62.98 $250.00
Average True Range (ATR) 1.54 8.22
MACD 0.04 -1.40
Stochastic Oscillator 44.53 19.77

Price Performance

Historical Comparison
KR
NTRA

About KR Kroger Company (The)

Kroger is one of the largest grocery retailers in the United States with about 2,700 stores across a portfolio of more than 20 supermarket banners. The company boasts an ingrained presence in US communities, citing that it is a top-two grocer in most of its major market areas. Over one fourth of Kroger's roughly $110 billion in nonperishable and fresh food sales (about 75% of revenue) stems from its private-label portfolio, of which the company manufactures about 30% of units via its own food production plants. The company also operates fuel stations and pharmacies at 60% and 80% of its locations, respectively.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: